A Study to Establish a Registry of Post-COVID Investigations, Education and Symptom Management

Overview

About this study

The purpose of this study is to establish a registry that will follow patients that are seen in the PCCOC clinic with Post-COVID symptoms that persist for greater than 28 days. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Mayo Clinic patients with a previously confirmed infection with the novel SARS-CoV-2 virus who have been seen in the PCOC, CARP, Pulmonary for post COVID clinic, Neurology, or approval by MAGPIES research group.
  • Aged  5 years and older.
  • All racial and ethnic groups are eligible.
  • Women with a previously confirmed infection with the novel SARS-CoV-2 virus of childbearing potential and pregnant women will be offered enrollment because there is no risk to an unborn child in this investigation. 

Exclusion Criteria:

  • Lacking the capacity to consent.
  • Prisoners and institutionalized individuals.
  • Non-English speakers will be enrolled into the study but will not be specifically targeted.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Arya Mohabbat, M.D.

Closed for enrollment

Contact information:

Gillian Currie M.B.A., CCRP

(507) 266-3223

Currie.Gillian@mayo.edu

More information

Publications

Publications are currently not available
.

Mayo Clinic Footer